Current research is exploring the use of BPC-157 in experimental settings for conditions such as: Musculoskeletal injuries (tendons, ligaments, muscles) Gut lining repair and inflammatory bowel conditions Post-operative recovery Inflammatory-related disorders It is important to note that evidence in humans is still emerging, and use should always be discussed with a qualified clinician who can evaluate safety, dosage, and appropriateness on a case-by-case basis
However, with GLP-1 RAs, it generally takes some time to start seeing the results of the treatment
METHODS: This quasi-experimental study was conducted at Isra University, Hyderabad from June 2017 to August 2017
Many people hear the word and immediately think of something negative, but inflammation itself is not the problem
The most common side effect is irritation at the site of injection which could last up to 5-10 minutes
They may not have Dihexa-specific guidance but can speak to your overall medication situation